Influenza and Pertussis Maternal Vaccination Coverage and Influencing Factors in Spain: A Study Based on Primary Care Records Registry.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
06 04 2022
Historique:
received: 01 02 2022
revised: 31 03 2022
accepted: 01 04 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 14 4 2022
Statut: epublish

Résumé

The purpose was to determine the coverage of maternal vaccination against influenza and pertussis, and the characteristics associated with being vaccinated, in a health area of Catalonia, Spain. Some 36,032 anonymized and computerized clinical records registries of pregnant women from Primary Care Centres (e-CAP database) were analysed, from between 2015 and 2018. Vaccination coverage and the association with sociodemographic variables and clinical conditions were estimated using a Poisson regression model. Maternal vaccination coverage against influenza ranged between 11.9% in 2015 and 6.8% in 2018, following a decreasing trend (p < 0.001). Coverage with the tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine varied between 49.8% in 2016 and 79.4% in 2018, following an increasing trend (p < 0.001). Having living children and suffering from obesity were factors associated with not being vaccinated against both infections. The predictive variables of vaccination against influenza were diabetes (IRR: 2.17, 95% CI: 1.42−3.30) and asthma (IRR: 2.05, 95% CI: 1.76−2.38); and for pertussis, it was asthma (IRR: 1.10, 95% CI: 1.03−1.17). Different socio-demographic factors and chronic conditions in pregnant women were associated with maternal vaccination, and which will have to be taken into account in clinical practice when implementing strategies to improve the coverage of the programme.

Identifiants

pubmed: 35410075
pii: ijerph19074391
doi: 10.3390/ijerph19074391
pmc: PMC8998305
pii:
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

JAMA Netw Open. 2021 Mar 1;4(3):e211793
pubmed: 33755165
Vaccine. 2015 Apr 27;33(18):2125-31
pubmed: 25796339
Public Health Rep. 2021 Nov-Dec;136(6):699-709
pubmed: 33508208
Public Health. 2018 Sep;162:111-117
pubmed: 30007172
Euro Surveill. 2018 Oct;23(43):
pubmed: 30376915
MMWR Recomm Rep. 2004 May 28;53(RR-6):1-40
pubmed: 15163927
Vaccines (Basel). 2020 Nov 30;8(4):
pubmed: 33266212
Medicina (Kaunas). 2021 Sep 17;57(9):
pubmed: 34577900
Matern Child Health J. 2018 Jul;22(7):1016-1024
pubmed: 29417364
Obstet Gynecol. 2017 Mar;129(3):560-573
pubmed: 28178054
Vaccine. 2016 Nov 11;34(47):5785-5791
pubmed: 27742214
N Engl J Med. 2013 Jan 24;368(4):333-40
pubmed: 23323868
Vaccine. 2015 May 5;33(19):2213-2220
pubmed: 25825331
Vaccine. 2017 Jan 23;35(4):521-528
pubmed: 28024955
Acta Obstet Gynecol Scand. 2021 Jun;100(6):997-1009
pubmed: 33420724
Vaccine. 2013 Jan 11;31(4):618-25
pubmed: 23200883
BMC Pregnancy Childbirth. 2018 Oct 24;18(1):416
pubmed: 30355329
Vaccine. 2015 Feb 18;33(8):1056-62
pubmed: 25573035
Clin Infect Dis. 2019 May 2;68(10):1634-1640
pubmed: 30169627
Prev Med. 2017 Jun;99:111-117
pubmed: 28216380
Vaccine. 2016 Jun 8;34(27):3149-3155
pubmed: 27161997
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Int J Environ Res Public Health. 2021 Jan 15;18(2):
pubmed: 33467755
Lancet. 2014 Oct 25;384(9953):1521-8
pubmed: 25037990
J Clin Nurs. 2016 Oct;25(19-20):2730-44
pubmed: 27206347
Best Pract Res Clin Obstet Gynaecol. 2021 Oct;76:53-65
pubmed: 33965331
BMJ. 2011 Jun 14;342:d3214
pubmed: 21672992
J Public Health (Oxf). 2021 Apr 12;43(1):148-154
pubmed: 31294802
Eur J Public Health. 2015 Dec;25(6):1053-8
pubmed: 25843827
J Hosp Infect. 2016 Oct;94(2):133-42
pubmed: 27546456
Euro Surveill. 2014 Apr 24;19(16):20780
pubmed: 24786262
MMWR Morb Mortal Wkly Rep. 2019 Oct 11;68(40):885-892
pubmed: 31600186
PLoS One. 2021 Mar 29;16(3):e0244181
pubmed: 33780460
Vaccine. 2018 Nov 26;36(49):7445-7455
pubmed: 30377064
Vaccine. 2018 Nov 29;36(50):7625-7631
pubmed: 30401620
BMC Pregnancy Childbirth. 2013 Jun 27;13:138
pubmed: 23806122
PLoS One. 2018 Jun 14;13(6):e0197867
pubmed: 29902184
Vaccine. 2018 May 11;36(20):2751-2759
pubmed: 29661584
Vaccine. 2016 Mar 14;34(12):1423-5
pubmed: 26562318
Euro Surveill. 2014 Nov 13;19(45):20959
pubmed: 25411687

Auteurs

María Isabel Fernández-Cano (MI)

Department of Nursing, Faculty of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Grup de Recerca Multidisciplinar en Salut i Societat (GREMSAS), (2017 SGR 917), 08007 Barcelona, Spain.

Antonia Arreciado Marañón (A)

Department of Nursing, Faculty of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Grup de Recerca Multidisciplinar en Salut i Societat (GREMSAS), (2017 SGR 917), 08007 Barcelona, Spain.

Azahara Reyes-Lacalle (A)

Atenció a la Salut Sexual i Reproductiva de Sabadell, Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, 08203 Barcelona, Spain.
Research Group Atenció a la Salut Sexual i Reproductiva (GRASSIR), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08007 Barcelona, Spain.

Maria Feijoo-Cid (M)

Department of Nursing, Faculty of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Grup de Recerca Multidisciplinar en Salut i Societat (GREMSAS), (2017 SGR 917), 08007 Barcelona, Spain.

Josep Maria Manresa-Domínguez (JM)

Department of Nursing, Faculty of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Grup de Recerca Multidisciplinar en Salut i Societat (GREMSAS), (2017 SGR 917), 08007 Barcelona, Spain.
Research Support Unit Metropolitana Nord, Primary Care Research Institut Jordi Gol (IDIAPJGol), 08303 Barcelona, Spain.

Laura Montero-Pons (L)

Research Group Atenció a la Salut Sexual i Reproductiva (GRASSIR), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08007 Barcelona, Spain.
Atenció a la Salut Sexual i Reproductiva de Santa Coloma de Gramenet, Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, 08921 Barcelona, Spain.

Rosa Maria Cabedo-Ferreiro (RM)

Research Group Atenció a la Salut Sexual i Reproductiva (GRASSIR), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08007 Barcelona, Spain.
Atenció a la Salut Sexual i Reproductiva de Granollers, Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, 08400 Barcelona, Spain.

Pere Toran-Monserrat (P)

Research Support Unit Metropolitana Nord, Primary Care Research Institut Jordi Gol (IDIAPJGol), 08303 Barcelona, Spain.
Department of Medicine, Faculty of Medicine, Universitat de Girona, 17071 Girona, Spain.

Gemma Falguera-Puig (G)

Research Group Atenció a la Salut Sexual i Reproductiva (GRASSIR), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08007 Barcelona, Spain.
Atenció a la Salut Sexual i Reproductiva Metropolitana Nord, Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, 08911 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH